Differences

This shows you the differences between two versions of the page.

--- celia_lourenco [2022/04/24 06:58]
liam [Health Canada]
+++ celia_lourenco [2022/04/24 08:38] (current)
liam [International Council for Harmonization]
@@ Line 12: / Line 12: @@
 ==== Health Canada ====
-Lourenco is the Director General of the [[Biologics and Genetic Therapies Directorate]] (BGTD) of the Health Products and Food Branch at [[Health Canada]]. She began in this role in November 2018.((//Celia Lourenco, PhD.// Canadian Society for Pharmaceutical Sciences. Retrieved April 23, 2022, from https://web.archive.org/web/20220424043122/http://www.cspscanada.org/wp-content/uploads/Celia-Lourenco-Bio.pdf)) In this role, she serves as an ex-officio representative on the [[National Advisory Committee on Immunization]] (NACI).((Public Health Agency of Canada. (2022, February 25). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://web.archive.org/web/20220318105951/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html#fn1-rf))
+Lourenco is the Director General of the [[Biologics and Genetic Therapies Directorate]] (BGTD) of the Health Products and Food Branch at [[Health Canada]]. She began in this role in November 2018.((//Celia Lourenco, PhD.// Canadian Society for Pharmaceutical Sciences. Retrieved April 23, 2022, from https://web.archive.org/web/20220424043122/http://www.cspscanada.org/wp-content/uploads/Celia-Lourenco-Bio.pdf)) In this role, she serves as an ex-officio representative on the [[National Advisory Committee on Immunization]] (NACI).((Public Health Agency of Canada. (2022, February 25). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://archive.ph/CDZrB))
 She was previously the Senior Executive Director of the [[Therapeutic Products Directorate]] (TPD)
 and held other management positions in the agency. She was Director of the Bureau of Gastroenterology, Infection and Viral Diseases;((Health Canada. (2016, October 3). //Final Record of Decisions - June 26, 2015, Meeting with National Association of Pharmacy Regulatory Authorities (NAPRA).// Government of Canada. https://archive.ph/K9wNS)) Associate Director of the Bureau of Cardiology, Allergy and Neurological Sciences; Interim Director of the Office of Clinical Trials; Manager of Clinical Group 1 at the Office of Clinical Trials; and Senior Clinical Evaluator.((//Celia Lourenco.// LinkedIn. Retrieved April 23, 2022, from https://www.linkedin.com/in/celia-lourenco-88a5bb13/details/experience/))
+==== International Council for Harmonization ====
+Lourenco formerly represented [[Health Canada]] at the Assembly and Management Committee of the [[International Council for Harmonization]] (ICH), where she served as Assembly and Management Committee Vice-chair.((//Members.// (2020, July 29). Wayback Machine; International Council for Harmonization. https://archive.ph/WqNbG))
+==== International Pharmaceutical Regulators Programme ====
+Lourenco has represented [[Health Canada]] at the [[International Pharmaceutical Regulators Programme]] (IPRP).((//IPRF agrees on a path forward and a new name – the International Pharmaceutical Regulators Programme (IPRP) – for the consolidation of its operations with the IGDRP.// (2017, November 12). International Pharmaceutical Regulators Programme. https://archive.ph/PNR1g))